DXCM logo DexCom +
DexCom
+

DexCom Overview

Company: DexCom
CEO: Jacob Steven Leach
Symbol: DXCM
Exchange: NASDAQ
Industry: Medical - Devices
Sector: Healthcare
About

DexCom, a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its productslude DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom wasorporated in 1999 and is headquartered in San Diego, California.

Continue reading...

DexCom (DXCM)

  • Stock Price
  • Volume
73.74 -17.68 -19.34%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

DexCom annual revenue was $4.66 B in 2025.

Net Income

DexCom annual net income was $836.30 M in 2025.

Employees

DexCom annual employee count was 11,100 in 2025.

Revenue by Segment

No Data Available !!

Revenue by Region

DexCom’s revenue by region: Non-US: $1.33 B in 2025.

Executive Salary

Kevin Sayer Executive Chairman, at DexCom, makes $16.28 M in total c...

Revenue per Employee

DexCom revenue per employee was $420.00 K in 2025.

Profit per Employee

DexCom profit per employee was $75.34 K in 2025.

Income Statement

Operating Income

DexCom annual operating income was $911.80 M in 2025.

Research & Development

DexCom annual research & development expense was $599.10 M in 2025.

Tax Rate (%)

DexCom annual Tax Rate was 23.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

DexCom annual total assets was $6.34 B in 2025.

Total Liabilities

DexCom annual total liabilities was $3.59 B in 2025.

Capital Expenditure

DexCom annual capital expenditures was -$363.50 M in 2025.

Ratios

Return on Equity (ROE)

DexCom annual return on equity(ROE) was 30.46% in 2025.

Return on Assets (ROA)

DexCom annual return on assets(ROA) was 13.19% in 2025.

Debt to Equity

DexCom annual debt to equity was 50.61% in 2025.

Profitability

Gross Profit Margin (%)

DexCom annual gross profit margin was 60.10% in 2025.

Operating Income Margin (%)

DexCom annual operating income margin was 19.56% in 2025.

Net Income Margin (%)

DexCom annual net income margin was 17.94% in 2025.

Earning Per Share

DexCom annual earning per share was $2.14 in 2025.

EBITDA

DexCom annual EBITDA was $1.16 B in 2025.

Free Cash Flow (FCF)

DexCom annual free cash flow(FCF) was $1.08 B in 2025.

Valuation

Enterprise value

DexCom annual enterprise value was $26.39 B in 2025.

Enterprise value to Revenue

DexCom annual enterprise value to revenue was 5.66 in 2025.

Enterprise value to EBITDA

DexCom annual enterprise value to EBITDA was 22.68 in 2025.

Competitors’ Revenue

Frequently Asked Questions

Who is the CEO of DexCom?

Jacob Steven Leach is the CEO of DexCom.

What industry and sector is DexCom in?

DexCom operates in the Medical - Devices industry and the Healthcare sector.

What are DexCom's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0001093557
  • SIC (Standard Industrial Classification):
  • ISIN (International Securities Identification Number): US2521311074

Sign up for free to view

How many employees does DexCom have?

DexCom has 11,100 employees.

What is the revenue of DexCom?

In fiscal year 2025, DexCom generated a revenue of $4.66 Billion.

What is the net income of DexCom?

In fiscal year 2025, DexCom reported a net income of $836.30 Million.

What is DexCom's biggest product segment?

When was DexCom listed on the stock exchange?

DexCom went public on Apr 14, 2005, through its Initial Public Offering (IPO), and it has been 21 years since then.

Sign up for free to view

What is the ticker symbol of DexCom, and where is it listed?

DexCom's ticker symbol is DXCM, and the company is listed on the NASDAQ stock market exchange.

What is DexCom's current stock price?

DexCom's current stock price is $73.76 as of May 30, 2026.

What is DexCom's market capitalization?

As of , DexCom's market cap is .

What is DexCom's ranking in the world?

Ranked #60among 2,804 companies based on market cap.

Who are the top competitors of DexCom?

Competitors of DexCom include Stryker Corporation, Abbott Laboratories and Boston Scientific Corporation, and more.

Related company

Submit feedback to Bullfincher